Gilead Sciences, Inc.
- SEC CIK
- 0000882095
- Latest filing
- Aug 3, 2026
KYTX holding history
Kyverna Therapeutics, Inc. in every 13F filed by Gilead Sciences, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KYTX overviewAll 13F holders of KYTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 4,126,119
- Value
- $36.8M
- % of portfolio
- 2.2%
- Quarters held
- 7
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 4,126,119 | $36.8M | 2.2% | 00.0% | Unchanged | Holders |
| Q1 2026 | 4,126,119 | $35.6M | 1.7% | 00.0% | Unchanged | Holders |
| Q4 2025 | 4,126,119 | $38.8M | 2.0% | 00.0% | Unchanged | Holders |
| Q3 2025 | 4,126,119 | $24.8M | 1.4% | 00.0% | Unchanged | Holders |
| Q2 2025 | 4,126,119 | $12.7M | 1.0% | 00.0% | Unchanged | Holders |
| Q1 2025 | 4,126,119 | $7.96M | 0.7% | 00.0% | Unchanged | Holders |
| Q4 2024 | 4,126,119 | $15.4M | 1.0% | – | No prior filing | Holders |